Physician profile
Michael Hood
NPI 1013036409
$315.70
in general payments reported to CMS, 2019-2025
10 companies · $119 in 2025
The $119 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $42.86 · 2022: $64.57 · 2023: $46.04 · 2024: $43.48 · 2025: $119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $208.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $62.15 | 2025 | General - Pain Management |
| Abbott Laboratories | $60.04 | 2021-2022 | |
| Nevro Corp. | $50.33 | 2023-2024 | Senza |
| Medtronic, INC. | $38.61 | 2025 | Inceptiv |
| Biodelivery Sciences International, INC. | $28.02 | 2021 | |
| Biogen, INC. | $19.37 | 2022 | |
| Ibsa Pharma INC. | $17.99 | 2025 | Licart, Flector, Tirosint |
| Vertos Medical, INC. | $14.58 | 2024 | Mild Device Kit |
| Si-Bone, INC. | $13.75 | 2023 | |
| Spr Therapeutics, INC | $10.86 | 2024 | Sprint Pns System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Hood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.